VDAC1 and Recurrent lower respiratory tract infections: These findings provide a potential target and theoretical foundation for the development of novel antiviral strategies targeting mitochondrial ion channels.IMPORTANCEThe study evaluates the antiviral activity of the VDAC1 inhibitor DIDS against respiratory syncytial virus (RSV), a major cause of lower respiratory tract infections worldwide.